<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04265937</url>
  </required_header>
  <id_info>
    <org_study_id>1905202-3</org_study_id>
    <nct_id>NCT04265937</nct_id>
  </id_info>
  <brief_title>Screening of Genetic Susceptibility Genes for Breast Cancer Patients in Chinese Communities</brief_title>
  <acronym>FDSCCBRCA-1</acronym>
  <official_title>Screening of Genetic Susceptibility Genes for Breast Cancer Patients and Establishment of High-risk Populations in Chinese Communities</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a community-based prospective study and the research object is breast cancer
      patients. It is planned to take the community as the unit to inform and collect the breast
      cancer patients who voluntarily participate to carry out the detection of BRCA1, BRCA2, PTEN,
      CHEK2 and PALB2 genes through the community health service center.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The frequency of Genetic Susceptibility Gene (BRCA1/2 etc) mutation</measure>
    <time_frame>1 year</time_frame>
    <description>Compare the frequency in different subgroup using chi-square testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prediction model of Genetic Susceptibility Gene (BRCA1/2 etc) mutation probability</measure>
    <time_frame>1 year</time_frame>
    <description>Logistic regression analysis was used to establish the prediction model.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breast cancer penetrance of Genetic Susceptibility Gene (BRCA1/2 etc) carriers</measure>
    <time_frame>1 year</time_frame>
    <description>Kaplan-Meier survival analysis and Kin-Cohort method were used to calculate the breast cancer penetrance.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Genetic Susceptibility</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Peripheral blood or oral mucosa samples.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Breast cancer patients from community.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  breast cancer patients of any age;

          -  both male and female;

          -  the subjects signed the informed consent to participate in the study and abide by the
             study procedure before being selected.

        Exclusion Criteria:

          -  healthy people or other malignant tumor patients without breast cancer;

          -  unable to interview the investigator and sign the informed consent due to any reason;

          -  it is impossible to collect peripheral blood or oral mucosa samples for any reason.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zhen Hu, MD</last_name>
    <phone>86 21 64175590</phone>
    <phone_ext>65010</phone_ext>
    <email>zhenhu@fudan.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhen Hu</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhen Hu, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>February 8, 2020</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2020</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Zhen Hu</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

